Vivani Medical Q4 EPS $(0.09) Beats $(0.10) Estimate.

Vivani Medical (NASDAQ: VANI) reported a Q4 loss of $(0.09) per share, surpassing the analyst estimate of $(0.10) by 10%. This represents an 18.18% improvement compared to losses of $(0.11) per share in the same quarter last year.